Mesoblast | MSB - SCHULD

Aktienkurs
2.12
Täglich Wechseln
-0.10 -4.50%
Monatlich
-1.85%
Jährlich
12.77%
Q2 Prognose
2.15




SCHULD Veränderung Datum
Avita Medical AUD 46.05M 1.46M 2025-12
Clinuvel Pharmaceuticals AUD 879.78K 189.09K 2024-06
Cochlear AUD 235.7M 10.9M 2025-06
CSL USD 11.96B 219M 2024-12
Pacific Edge NZD 2.9M 425K 2025-03
Paradigm Biopharmaceuticals AUD 181.4K 38.99K 2024-12
PYC Therapeutics AUD 1.02M 185.07K 2025-06
Ramsay Health Care AUD 12.12B 864.4M 2025-06
Sonic Healthcare AUD 4.8B 282.9M 2024-12
Starpharma Holdings AUD 2.4M 73K 2025-06
Telix Pharmaceuticals AUD 418.25M 163.2M 2025-06